![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/30/2920943/0/en/Phathom-Pharmaceuticals-Announces-VOQUEZNA-vonoprazan-Added-to-CVS-Caremark-Formularies-for-Commercially-Insured-Patients.html
https://www.globenewswire.com/news-release/2024/07/29/2920214/0/en/Phathom-Pharmaceuticals-to-Report-Second-Quarter-2024-Financial-Results-and-Provide-Business-Update-on-Thursday-August-8-2024.html
https://www.globenewswire.com/news-release/2024/07/18/2915240/0/en/Phathom-Pharmaceuticals-Announces-FDA-Approval-of-VOQUEZNA-vonoprazan-Tablets-for-the-Relief-of-Heartburn-Associated-with-Non-Erosive-GERD-in-Adults.html
https://www.globenewswire.com/news-release/2024/05/15/2882383/0/en/Phathom-Pharmaceuticals-to-Present-VOQUEZNA-vonoprazan-Data-at-DDW-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/09/2878702/0/en/Phathom-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/29/2871202/0/en/Phathom-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Business-Update-on-Thursday-May-9-2024.html
https://www.globenewswire.com/news-release/2024/04/03/2856858/0/en/Phathom-Pharmaceuticals-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://investors.phathompharma.com/news-releases/news-release-details/phathom-pharmaceuticals-launches-direct-consumer-campaign
https://endpts.com/another-pharma-adds-direct-telehealth-with-phathoms-first-campaign-for-acid-blocker-voquezna/
https://www.globenewswire.com/news-release/2024/03/26/2852310/0/en/Phathom-Pharmaceuticals-Launches-Direct-to-Consumer-Campaign-VOQUEZNA-Can-Kick-Some-Acid.html